Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Effect of Levocarnitine in Protecting the Liver
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Please view the study at clinicaltrials.gov for complete details.
IRB Study ID:
2024-056
Study Sponsor:
Children's Oncology Group
Full IRB Study Title:
ACCL1931: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Kelly Culp: 330-543-0108
Lead Investigator
Erin Wright, MD
Director, Neuro-Oncology; Director, Shannon E. Wilkes Targeted Therapy Program; Co-Director, Neurofibromatosis Clinic; Pediatric Neuro-Oncologist
Pediatric Brain Tumor ProgramShowers Family Center for Childhood Cancer and Blood DisordersNeurofibromatosis (NF) Clinic
